<?xml version='1.0' encoding='utf-8'?>
<document id="25537751"><sentence text="Co-Prescribing of Potentially Interacting Drugs during Warfarin Therapy - A Population-Based Register Study." /><sentence text="We analysed the occurrence of co-prescribing of potentially interacting drugs during warfarin therapy in the community-dwelling population of Finland" /><sentence text=" We identified drugs having interaction potential with warfarin using the Swedish Finnish INteraction X-referencing drug-drug interaction database (SFINX) and obtained data on drug purchases from the nationwide Prescription Register" /><sentence text=" We defined warfarin users as persons purchasing warfarin in 2010 (n = 148,536) and followed them from their first prescription in 2010 until the end of the calendar year" /><sentence text=" Co-prescribing was defined as at least 1-day overlap between warfarin and interacting drug episodes" /><sentence text=" In addition, we identified persons who initiated warfarin therapy between 1 January 2007 and 30 September 2010 (n = 110,299) and followed these incident users for a 3-month period since warfarin initiation" /><sentence text=" Overall, 74" /><sentence text="4% of warfarin users were co-prescribed interacting drugs" /><sentence text=" Co-prescribing covered 46" /><sentence text="4% of the total person-years of warfarin exposure" /><sentence text=" Interacting drugs that should be avoided with warfarin were co-prescribed for 13"><entity charOffset="47-55" id="DDI-PubMed.25537751.s11.e0" text="warfarin" /></sentence><sentence text="4% of warfarin users" /><sentence text=" The majority of the co-prescriptions were for drugs that are not contraindicated during warfarin therapy but require special consideration" /><sentence text=" Among incident users, 57" /><sentence text="1% purchased potentially interacting drugs during the 3-month period after initiation, while 9" /><sentence text="0% purchased interacting drugs that should be avoided with warfarin"><entity charOffset="59-67" id="DDI-PubMed.25537751.s16.e0" text="warfarin" /></sentence><sentence text=" To conclude, the occurrence of co-prescribing of potentially interacting drugs was high during warfarin therapy" /><sentence text=" Our findings highlight the importance of close monitoring of warfarin therapy and the need for further studies on the clinical consequences of co-prescribing of interacting drugs with warfarin"><entity charOffset="185-193" id="DDI-PubMed.25537751.s18.e0" text="warfarin" /></sentence><sentence text=" " /></document>